Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 222

1.

Contradiction between amide-CEST signal and pH in breast cancer explained with metabolic MRI.

Krikken E, van der Kemp WJM, Khlebnikov V, van Dalen T, Los M, van Laarhoven HWM, Luijten PR, van den Bosch MAAJ, Klomp DWJ, Wijnen JP.

NMR Biomed. 2019 Aug;32(8):e4110. doi: 10.1002/nbm.4110. Epub 2019 May 28.

PMID:
31136039
2.

MRI guided focal HDR brachytherapy for localized prostate cancer: Toxicity, biochemical outcome and quality of life.

Maenhout M, Peters M, Moerland MA, Meijer RP, van den Bosch MAAJ, Frank SJ, Nguyen PL, van Vulpen M, van der Voort van Zyp JRN.

Radiother Oncol. 2018 Dec;129(3):554-560. doi: 10.1016/j.radonc.2018.07.019. Epub 2018 Aug 18.

PMID:
30131183
3.

Additional hepatic 166Ho-radioembolization in patients with neuroendocrine tumours treated with 177Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial).

Braat AJAT, Kwekkeboom DJ, Kam BLR, Teunissen JJM, de Herder WW, Dreijerink KMA, van Rooij R, Krijger GC, de Jong HWAM, van den Bosch MAAJ, Lam MGEH.

BMC Gastroenterol. 2018 Jun 15;18(1):84. doi: 10.1186/s12876-018-0817-8.

4.

Accuracy of SPECT/CT-based lung dose calculation for Holmium-166 hepatic radioembolization before OSEM convergence.

van Nierop BJ, Prince JF, van Rooij R, van den Bosch MAAJ, Lam MGEH, de Jong HWAM.

Med Phys. 2018 Jun 1. doi: 10.1002/mp.13024. [Epub ahead of print]

5.

Radioembolisation in Europe: A Survey Amongst CIRSE Members.

Reinders MTM, Mees E, Powerski MJ, Bruijnen RCG, van den Bosch MAAJ, Lam MGEH, Smits MLJ.

Cardiovasc Intervent Radiol. 2018 Oct;41(10):1579-1589. doi: 10.1007/s00270-018-1982-4. Epub 2018 May 8.

6.

Focal MRI-Guided Salvage High-Dose-Rate Brachytherapy in Patients With Radiorecurrent Prostate Cancer.

Maenhout M, Peters M, van Vulpen M, Moerland MA, Meijer RP, van den Bosch MAAJ, Nguyen PL, Frank SJ, van der Voort van Zyp JRN.

Technol Cancer Res Treat. 2017 Dec;16(6):1194-1201. doi: 10.1177/1533034617741797. Epub 2017 Dec 5.

7.

Eligibility of patients for minimally invasive breast cancer therapy based on MRI analysis of tumor proximity to skin and pectoral muscle.

Merckel LG, Verburg E, van der Velden BHM, Loo CE, van den Bosch MAAJ, Gilhuijs KGA.

Breast J. 2018 Jul;24(4):501-508. doi: 10.1111/tbj.12984. Epub 2017 Dec 29.

PMID:
29286193
8.

Anatomic versus Metabolic Tumor Response Assessment after Radioembolization Treatment.

Jongen JMJ, Rosenbaum CENM, Braat MNGJA, van den Bosch MAAJ, Sze DY, Kranenburg O, Borel Rinkes IHM, Lam MGEH, van den Hoven AF.

J Vasc Interv Radiol. 2018 Feb;29(2):244-253.e2. doi: 10.1016/j.jvir.2017.09.024. Epub 2017 Dec 14.

PMID:
29249594
9.

Efficacy of Radioembolization with 166Ho-Microspheres in Salvage Patients with Liver Metastases: A Phase 2 Study.

Prince JF, van den Bosch MAAJ, Nijsen JFW, Smits MLJ, van den Hoven AF, Nikolakopoulos S, Wessels FJ, Bruijnen RCG, Braat MNGJA, Zonnenberg BA, Lam MGEH.

J Nucl Med. 2018 Apr;59(4):582-588. doi: 10.2967/jnumed.117.197194. Epub 2017 Sep 15.

10.

Safety analysis of holmium-166 microsphere scout dose imaging during radioembolisation work-up: A cohort study.

Braat AJAT, Prince JF, van Rooij R, Bruijnen RCG, van den Bosch MAAJ, Lam MGEH.

Eur Radiol. 2018 Mar;28(3):920-928. doi: 10.1007/s00330-017-4998-2. Epub 2017 Aug 7.

11.

Early health technology assessment of magnetic resonance-guided high intensity focused ultrasound ablation for the treatment of early-stage breast cancer.

Knuttel FM, Huijsse SEM, Feenstra TL, Moonen CTW, van den Bosch MAAJ, Buskens E, Greuter MJW, de Bock GH.

J Ther Ultrasound. 2017 Aug 1;5:23. doi: 10.1186/s40349-017-0101-3. eCollection 2017.

12.

Recommendations for radioembolisation after liver surgery using yttrium-90 resin microspheres based on a survey of an international expert panel.

Samim M, van Veenendaal LM, Braat MNGJA, van den Hoven AF, Van Hillegersberg R, Sangro B, Kao YH, Liu D, Louie JD, Sze DY, Rose SC, Brown DB, Ahmadzadehfar H, Kim E, van den Bosch MAAJ, Lam MGEH.

Eur Radiol. 2017 Dec;27(12):4923-4930. doi: 10.1007/s00330-017-4889-6. Epub 2017 Jul 3.

13.

Thermal ablation of a confluent lesion in the porcine kidney with a clinically available MR-HIFU system.

van Breugel JMM, de Greef M, Wijlemans JW, Schubert G, van den Bosch MAAJ, Moonen CTW, Ries MG.

Phys Med Biol. 2017 Jul 7;62(13):5312-5326. doi: 10.1088/1361-6560/aa75b3. Epub 2017 May 30.

PMID:
28557798
14.

Perception of safety is a prerequisite for the association between neighbourhood green qualities and physical activity: Results from a cross-sectional study in Sweden.

Weimann H, Rylander L, van den Bosch MA, Albin M, Skärbäck E, Grahn P, Björk J.

Health Place. 2017 May;45:124-130. doi: 10.1016/j.healthplace.2017.03.011. Epub 2017 Mar 27.

PMID:
28359908
15.

The diagnostic performance of 18F-FDG PET/CT, CT and MRI in the treatment evaluation of ablation therapy for colorectal liver metastases: A systematic review and meta-analysis.

Samim M, Molenaar IQ, Seesing MF, van Rossum PS, van den Bosch MA, Ruers TJ, Borel Rinkes IH, van Hillegersberg R, Lam MG, Verkooijen HM.

Surg Oncol. 2017 Mar;26(1):37-45. doi: 10.1016/j.suronc.2016.12.006. Epub 2016 Dec 29. Review.

PMID:
28317583
16.

Patient Preferences for Minimally Invasive and Open Locoregional Treatment for Early-Stage Breast Cancer.

Knuttel FM, van den Bosch MA, Young-Afat DA, Emaus MJ, van den Bongard DH, Witkamp AJ, Verkooijen HM.

Value Health. 2017 Mar;20(3):474-480. doi: 10.1016/j.jval.2016.10.013. Epub 2016 Dec 22.

17.

Moderate-to-deep sedation technique, using propofol and ketamine, allowing synchronised breathing for magnetic resonance high-intensity focused ultrasound (MR-HIFU) treatment for uterine fibroids: a pilot study.

Vaessen HHB, Knuttel FM, van Breugel JMM, Ikink ME, Dieleman JM, van den Bosch MAAJ, Knape JTA.

J Ther Ultrasound. 2017 Feb 9;5:8. doi: 10.1186/s40349-017-0088-9. eCollection 2017.

18.

18F-FDG PET as novel imaging biomarker for disease progression after ablation therapy in colorectal liver metastases.

Samim M, Prevoo W, de Wit-van der Veen BJ, Kuhlmann KF, Ruers T, van Hillegersberg R, van den Bosch MAAJ, Verkooijen HM, Lam MGEH, Stokkel MPM.

Eur J Nucl Med Mol Imaging. 2017 Jul;44(7):1165-1175. doi: 10.1007/s00259-017-3637-0. Epub 2017 Feb 8.

19.

Lung Shunting: An Indicator of Survival, But Not Necessarily a Tool for Selecting Patients for Radioembolization.

Smits ML, Bastiaannet R, Prince JF, de Jong HW, van den Bosch MA, Lam MG.

Radiology. 2017 Feb;282(2):612-613. doi: 10.1148/radiol.2017162087. No abstract available.

PMID:
28099100
20.

Hepatobiliary scintigraphy may improve radioembolization treatment planning in HCC patients.

Braat MNGJA, de Jong HW, Seinstra BA, Scholten MV, van den Bosch MAAJ, Lam MGEH.

EJNMMI Res. 2017 Dec;7(1):2. doi: 10.1186/s13550-016-0248-x. Epub 2017 Jan 5.

21.

Yttrium-90 radioembolization for colorectal cancer liver metastases: a prospective cohort study on circulating angiogenic factors and treatment response.

Rosenbaum CE, van den Hoven AF, Braat MN, Koopman M, Lam MG, Zonnenberg BA, Verkooijen HM, van den Bosch MA.

EJNMMI Res. 2016 Dec;6(1):92. doi: 10.1186/s13550-016-0236-1. Epub 2016 Dec 21.

22.

Radioembolization-induced liver disease: a systematic review.

Braat MN, van Erpecum KJ, Zonnenberg BA, van den Bosch MA, Lam MG.

Eur J Gastroenterol Hepatol. 2017 Feb;29(2):144-152. doi: 10.1097/MEG.0000000000000772. Review.

PMID:
27926660
23.

Surefire infusion system versus standard microcatheter use during holmium-166 radioembolization: study protocol for a randomized controlled trial.

van den Hoven AF, Prince JF, Bruijnen RC, Verkooijen HM, Krijger GC, Lam MG, van den Bosch MA.

Trials. 2016 Oct 25;17(1):520.

24.

The role of 90Y-radioembolization in downstaging primary and secondary hepatic malignancies: a systematic review.

Braat MN, Samim M, van den Bosch MA, Lam MG.

Clin Transl Imaging. 2016;4:283-295. Epub 2016 Apr 23. Review.

25.

Procedural sedation and analgesia for respiratory-gated MR-HIFU in the liver: a feasibility study.

van Breugel JM, Wijlemans JW, Vaessen HH, de Greef M, Moonen CT, van den Bosch MA, Ries MG.

J Ther Ultrasound. 2016 Jul 29;4:19. doi: 10.1186/s40349-016-0063-x. eCollection 2016.

26.

Erratum to: Dynamic contrast-enhanced breast MRI at 7T and 3T: an intra-individual comparison study.

Menezes GL, Stehouwer BL, Klomp DW, van der Velden TA, van den Bosch MA, Knuttel FM, Boer VO, van der Kemp WJ, Luijten PR, Veldhuis WB.

Springerplus. 2016 Jul 7;5(1):1012. doi: 10.1186/s40064-016-2514-9. eCollection 2016.

27.

High-resolution T2-weighted cervical cancer imaging: a feasibility study on ultra-high-field 7.0-T MRI with an endorectal monopole antenna.

Hoogendam JP, Kalleveen IM, de Castro CS, Raaijmakers AJ, Verheijen RH, van den Bosch MA, Klomp DW, Zweemer RP, Veldhuis WB.

Eur Radiol. 2017 Mar;27(3):938-945. doi: 10.1007/s00330-016-4419-y. Epub 2016 May 31.

28.

Liver CT for vascular mapping during radioembolisation workup: comparison of an early and late arterial phase protocol.

van den Hoven AF, Braat MN, Prince JF, van Doormaal PJ, van Leeuwen MS, Lam MG, van den Bosch MA.

Eur Radiol. 2017 Jan;27(1):61-69. Epub 2016 Apr 23.

29.

The Caudate Lobe: The Blind Spot in Radioembolization or an Overlooked Opportunity?

Braat MN, van den Hoven AF, van Doormaal PJ, Bruijnen RC, Lam MG, van den Bosch MA.

Cardiovasc Intervent Radiol. 2016 Jun;39(6):847-54. doi: 10.1007/s00270-016-1321-6. Epub 2016 Mar 21.

PMID:
27001228
30.

Meta-analysis of the concordance of histological grade of breast cancer between core needle biopsy and surgical excision specimen.

Knuttel FM, Menezes GL, van Diest PJ, Witkamp AJ, van den Bosch MA, Verkooijen HM.

Br J Surg. 2016 May;103(6):644-655. doi: 10.1002/bjs.10128. Epub 2016 Mar 15. Review.

PMID:
26990850
31.

Insights into the Dose-Response Relationship of Radioembolization with Resin 90Y-Microspheres: A Prospective Cohort Study in Patients with Colorectal Cancer Liver Metastases.

van den Hoven AF, Rosenbaum CE, Elias SG, de Jong HW, Koopman M, Verkooijen HM, Alavi A, van den Bosch MA, Lam MG.

J Nucl Med. 2016 Jul;57(7):1014-9. doi: 10.2967/jnumed.115.166942. Epub 2016 Feb 23.

32.

Prediction Model For Extensive Ductal Carcinoma In Situ Around Early-Stage Invasive Breast Cancer.

Knuttel FM, van der Velden BH, Loo CE, Elias SG, Wesseling J, van den Bosch MA, Gilhuijs KG.

Invest Radiol. 2016 Jul;51(7):462-8. doi: 10.1097/RLI.0000000000000255.

PMID:
26863579
33.

First clinical experience with a dedicated MRI-guided high-intensity focused ultrasound system for breast cancer ablation.

Merckel LG, Knuttel FM, Deckers R, van Dalen T, Schubert G, Peters NH, Weits T, van Diest PJ, Mali WP, Vaessen PH, van Gorp JM, Moonen CT, Bartels LW, van den Bosch MA.

Eur Radiol. 2016 Nov;26(11):4037-4046. Epub 2016 Feb 6.

34.

Dynamic contrast-enhanced breast MRI at 7T and 3T: an intra-individual comparison study.

Menezes GL, Stehouwer BL, Klomp DW, van der Velden TA, van den Bosch MA, Knuttel FM, Boer VO, van der Kemp WJ, Luijten PR, Veldhuis WB.

Springerplus. 2016 Jan 5;5:13. doi: 10.1186/s40064-015-1654-7. eCollection 2016. Erratum in: Springerplus. 2016;5(1):1012.

35.

Histopathology of breast cancer after magnetic resonance-guided high-intensity focused ultrasound and radiofrequency ablation.

Knuttel FM, Waaijer L, Merckel LG, van den Bosch MA, Witkamp AJ, Deckers R, van Diest PJ.

Histopathology. 2016 Aug;69(2):250-9. doi: 10.1111/his.12926. Epub 2016 Feb 14.

PMID:
26732321
36.

Non-invasive magnetic resonance-guided high intensity focused ultrasound ablation of a vascular malformation in the lower extremity: a case report.

van Breugel JM, Nijenhuis RJ, Ries MG, Toorop RJ, Vonken EJ, Wijlemans JW, van den Bosch MA.

J Ther Ultrasound. 2015 Dec 30;3:23. doi: 10.1186/s40349-015-0042-7. eCollection 2015.

37.

99mTc-Nanocolloid SPECT/MRI Fusion for the Selective Assessment of Nonenlarged Sentinel Lymph Nodes in Patients with Early-Stage Cervical Cancer.

Hoogendam JP, Zweemer RP, Hobbelink MG, van den Bosch MA, Verheijen RH, Veldhuis WB.

J Nucl Med. 2016 Apr;57(4):551-6. doi: 10.2967/jnumed.115.164780. Epub 2015 Dec 17.

38.

Non-Invasive Targeted Peripheral Nerve Ablation Using 3D MR Neurography and MRI-Guided High-Intensity Focused Ultrasound (MR-HIFU): Pilot Study in a Swine Model.

Huisman M, Staruch RM, Ladouceur-Wodzak M, van den Bosch MA, Burns DK, Chhabra A, Chopra R.

PLoS One. 2015 Dec 14;10(12):e0144742. doi: 10.1371/journal.pone.0144742. eCollection 2015.

39.

High Prevalence of MRI-Detected Contralateral and Ipsilateral Malignant Findings in Patients With Invasive Ductolobular Breast Cancer: Impact on Surgical Management.

El Sharouni MA, Postma EL, Menezes GL, van den Bosch MA, Pijnappel RM, Witkamp AJ, van der Pol CC, Verkooijen HM, van Diest PJ.

Clin Breast Cancer. 2016 Aug;16(4):269-75. doi: 10.1016/j.clbc.2015.10.002. Epub 2015 Nov 10.

PMID:
26639066
40.

Magnetic Resonance-Guided High Intensity Focused Ultrasound Ablation of Breast Cancer.

Knuttel FM, van den Bosch MA.

Adv Exp Med Biol. 2016;880:65-81. doi: 10.1007/978-3-319-22536-4_4. Review.

PMID:
26486332
41.

Volumetric MR-Guided High-Intensity Focused Ultrasound with Direct Skin Cooling for the Treatment of Symptomatic Uterine Fibroids: Proof-of-Concept Study.

Ikink ME, van Breugel JM, Schubert G, Nijenhuis RJ, Bartels LW, Moonen CT, van den Bosch MA.

Biomed Res Int. 2015;2015:684250. doi: 10.1155/2015/684250. Epub 2015 Aug 30.

42.

Innovation in catheter design for intra-arterial liver cancer treatments results in favorable particle-fluid dynamics.

van den Hoven AF, Lam MG, Jernigan S, van den Bosch MA, Buckner GD.

J Exp Clin Cancer Res. 2015 Aug 1;34:74. doi: 10.1186/s13046-015-0188-8.

43.

Moving to Serene Nature May Prevent Poor Mental Health--Results from a Swedish Longitudinal Cohort Study.

van den Bosch MA, Östergren PO, Grahn P, Skärbäck E, Währborg P.

Int J Environ Res Public Health. 2015 Jul 14;12(7):7974-89. doi: 10.3390/ijerph120707974.

44.

Development of a High-Throughput Molecular Imaging-Based Orthotopic Hepatocellular Carcinoma Model.

Hwang GL, van den Bosch MA, Kim YI, Katzenberg R, Willmann JK, Paulmurugan R, Gambhir SS, Hofmann L.

Cureus. 2015 Jun 27;7(6):e281. doi: 10.7759/cureus.281. eCollection 2015 Jun.

45.

No Value for Routine Chest Radiography in the Work-Up of Early Stage Cervical Cancer Patients.

Hoogendam JP, Zweemer RP, Verkooijen HM, de Jong PA, van den Bosch MA, Verheijen RH, Veldhuis WB.

PLoS One. 2015 Jul 2;10(7):e0131899. doi: 10.1371/journal.pone.0131899. eCollection 2015.

46.

Performance analysis of a dedicated breast MR-HIFU system for tumor ablation in breast cancer patients.

Deckers R, Merckel LG, Denis de Senneville B, Schubert G, Köhler M, Knuttel FM, Mali WP, Moonen CT, van den Bosch MA, Bartels LW.

Phys Med Biol. 2015 Jul 21;60(14):5527-42. doi: 10.1088/0031-9155/60/14/5527. Epub 2015 Jul 2.

PMID:
26133986
47.

MR Imaging as an Additional Screening Modality for the Detection of Breast Cancer in Women Aged 50-75 Years with Extremely Dense Breasts: The DENSE Trial Study Design.

Emaus MJ, Bakker MF, Peeters PH, Loo CE, Mann RM, de Jong MD, Bisschops RH, Veltman J, Duvivier KM, Lobbes MB, Pijnappel RM, Karssemeijer N, de Koning HJ, van den Bosch MA, Monninkhof EM, Mali WP, Veldhuis WB, van Gils CH.

Radiology. 2015 Nov;277(2):527-37. doi: 10.1148/radiol.2015141827. Epub 2015 Jun 23.

PMID:
26110667
48.

Use of C-Arm Cone Beam CT During Hepatic Radioembolization: Protocol Optimization for Extrahepatic Shunting and Parenchymal Enhancement.

van den Hoven AF, Prince JF, de Keizer B, Vonken EJ, Bruijnen RC, Verkooijen HM, Lam MG, van den Bosch MA.

Cardiovasc Intervent Radiol. 2016 Jan;39(1):64-73. doi: 10.1007/s00270-015-1146-8. Epub 2015 Jun 12.

49.

[18F]Fluorodeoxyglucose PET for Interventional Oncology in Liver Malignancy.

Samim M, El-Haddad GE, Molenaar IQ, Prevoo W, van den Bosch MA, Alavi A, Lam MG.

PET Clin. 2014 Oct;9(4):469-95, vi. doi: 10.1016/j.cpet.2014.07.004. Epub 2014 Aug 12. Review.

PMID:
26050948
50.

Effectiveness of Repeat Radiotherapy for Painful Bone Metastases in Clinical Practice: A 10 Year Historical Cohort Study.

Huisman M, Verkooijen HM, van der Linden YM, van den Bosch MA, van Vulpen M.

Clin Oncol (R Coll Radiol). 2015 Aug;27(8):472-8. doi: 10.1016/j.clon.2015.04.005. Epub 2015 May 23.

PMID:
26004238

Supplemental Content

Loading ...
Support Center